Epidemiology and prognosis of PTLD after HSCT

Vikas R. Dharnidharka; Thomas G. Gross

doi:10.1007/978-3-030-65403-0_12

Epidemiology and prognosis of PTLD after HSCT

Vikas R. Dharnidharka, Thomas G. Gross

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

1 Scopus citations

Abstract

PTLD is a relatively rare but important and feared complication of hematopoietic stem cell transplantation (HSCT). Several different types of risk factors (infectious, type of transplant, immunosuppression) are associated with PTLD development after HSCT. Most PTLD cases after HSCT are Epstein-Barr virus positive. Most PTLD cases occur early after HSCT and the survival after PTLD is poor.

Original language	English
Title of host publication	Post-Transplant Lymphoproliferative Disorders
Publisher	Springer International Publishing
Pages	209-216
Number of pages	8
ISBN (Electronic)	9783030654030
ISBN (Print)	9783030654023
DOIs	https://doi.org/10.1007/978-3-030-65403-0_12
State	Published - Feb 11 2021

Keywords

Epidemiology
Hematopoietic stem cell transplant
Post-transplant lymphoproliferative disorders
Prognostic factors
Risk factors

Access to Document

10.1007/978-3-030-65403-0_12

Cite this

@inbook{bc64800030714482b7db1f32d465b7d4,

title = "Epidemiology and prognosis of PTLD after HSCT",

abstract = "PTLD is a relatively rare but important and feared complication of hematopoietic stem cell transplantation (HSCT). Several different types of risk factors (infectious, type of transplant, immunosuppression) are associated with PTLD development after HSCT. Most PTLD cases after HSCT are Epstein-Barr virus positive. Most PTLD cases occur early after HSCT and the survival after PTLD is poor.",

keywords = "Epidemiology, Hematopoietic stem cell transplant, Post-transplant lymphoproliferative disorders, Prognostic factors, Risk factors",

author = "Dharnidharka, {Vikas R.} and Gross, {Thomas G.}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2021.",

year = "2021",

month = feb,

day = "11",

doi = "10.1007/978-3-030-65403-0_12",

language = "English",

isbn = "9783030654023",

pages = "209--216",

booktitle = "Post-Transplant Lymphoproliferative Disorders",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Epidemiology and prognosis of PTLD after HSCT

AU - Dharnidharka, Vikas R.

AU - Gross, Thomas G.

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2021.

PY - 2021/2/11

Y1 - 2021/2/11

N2 - PTLD is a relatively rare but important and feared complication of hematopoietic stem cell transplantation (HSCT). Several different types of risk factors (infectious, type of transplant, immunosuppression) are associated with PTLD development after HSCT. Most PTLD cases after HSCT are Epstein-Barr virus positive. Most PTLD cases occur early after HSCT and the survival after PTLD is poor.

AB - PTLD is a relatively rare but important and feared complication of hematopoietic stem cell transplantation (HSCT). Several different types of risk factors (infectious, type of transplant, immunosuppression) are associated with PTLD development after HSCT. Most PTLD cases after HSCT are Epstein-Barr virus positive. Most PTLD cases occur early after HSCT and the survival after PTLD is poor.

KW - Epidemiology

KW - Hematopoietic stem cell transplant

KW - Post-transplant lymphoproliferative disorders

KW - Prognostic factors

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=85150842151&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-65403-0_12

DO - 10.1007/978-3-030-65403-0_12

M3 - Chapter

AN - SCOPUS:85150842151

SN - 9783030654023

SP - 209

EP - 216

BT - Post-Transplant Lymphoproliferative Disorders

PB - Springer International Publishing

ER -

Epidemiology and prognosis of PTLD after HSCT

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this